OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
Gian Loreto D’Alò, Franco De Crescenzo, Laura Amato, et al.
Health and Quality of Life Outcomes (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000–19 primary care data
Maja R. Radojčić, Matthias Pierce, Holly Hope, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 2, pp. 119-128
Open Access | Times Cited: 45

Emerging drugs for the treatment of irritability associated with autism spectrum disorder
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 45-56
Closed Access | Times Cited: 12

Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)
Michelle Iffland, Nuala Livingstone, Mikaela Jorgensen, et al.
Cochrane library (2023) Vol. 2023, Iss. 10
Closed Access | Times Cited: 20

Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews
Cecilia Fieiras, Michael Hao Chen, Camila Micaela Escobar Liquitay, et al.
BMJ evidence-based medicine (2022) Vol. 28, Iss. 1, pp. 7-14
Closed Access | Times Cited: 24

Pharmacological management of psychopathology in people with intellectual disabilities and/or autism spectrum disorder
Shoumitro Deb, Meera Roy, Bharati Limbu
BJPsych Advances (2022) Vol. 29, Iss. 5, pp. 322-333
Closed Access | Times Cited: 23

Randomised controlled trials of antipsychotics for people with autism spectrum disorder: a systematic review and a meta-analysis
Shoumitro Deb, Meera Roy, Bharati Limbu, et al.
Psychological Medicine (2023) Vol. 53, Iss. 16, pp. 7964-7972
Closed Access | Times Cited: 14

Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
Muhammad Shahid Nadeem, Salman Hosawi, Sultan Alshehri, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1635-1635
Open Access | Times Cited: 32

The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence
Denis Pavǎl
International review of neurobiology (2023), pp. 1-42
Closed Access | Times Cited: 11

Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms
Mariah A. Manter, Kirstin Birtwell, Jonathan Bath, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access

Effects of prefrontal transcranial direct current stimulation on social functioning in autism spectrum disorder: A randomized clinical trial
Yvonne M. Y. Han, Melody M.Y. Chan, Caroline KS Shea, et al.
Autism (2023) Vol. 27, Iss. 8, pp. 2465-2482
Closed Access | Times Cited: 8

Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder
Robyn P. Thom, Joseph A. Pereira, Danielle Sipsock, et al.
Current Psychiatry Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 17

Motor stereotypies in autism spectrum disorder: Clinical randomized study and classification proposal
Cláudia Melo, Tiago Ribeiro, C. Prior, et al.
Autism (2022) Vol. 27, Iss. 2, pp. 456-471
Closed Access | Times Cited: 12

An expert opinion on the pharmacological interventions for Disruptive Mood Dysregulation Disorder (DMDD)
Laura Orsolini, Giulio Longo, Angelica Cicolini, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 1, pp. 67-78
Closed Access | Times Cited: 2

Psychopharmacology
Shoumitro Deb
Autism and child psychopathology series (2024), pp. 395-416
Closed Access | Times Cited: 2

Psychopharmacological treatment of disruptive behavior in youths: systematic review and network meta-analysis
Ji‐Woo Seok, Brigette Soltis‐Vaughan, Brandon J. Lew, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5

Characterizing the physical and mental health profile of children, adolescents and adults with autism spectrum disorder in Spain
Ruth Vidriales-Fernández, Marta Plaza-Sanz, Cristina Hernández-Layna, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4

Use of second-generation antipsychotics in autism spectrum disorder: a systematic review and meta-analysis protocol
Luís Phillipe Nagem Lopes, Jardel Corrêa de Oliveira, Cristiane de Cássia Bergamaschi, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e069114-e069114
Open Access | Times Cited: 4

The Use of Psychotropic Medication in Iranian Children with Developmental Disabilities
Roy McConkey, Sayyed Ali Samadi, Ameneh Mahmoodizadeh, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 8, pp. 4120-4120
Open Access | Times Cited: 4

Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course
Samuele Cortese, Frank Besag, Bruce Clark, et al.
Journal of Psychopharmacology (2022) Vol. 37, Iss. 2, pp. 119-134
Open Access | Times Cited: 3

Characterizing the Clinical and Sociodemographic Profiles of Hospitalized Adolescents with Autism Spectrum Disorder
Matan Avrahami, David H. Ben-Dor, Roy Ratzon, et al.
Cambridge Prisms Global Mental Health (2024) Vol. 11
Open Access

Page 1 - Next Page

Scroll to top